GOLDMAN SACHS GROUP INC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 49 filers reported holding SOLENO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$124,000
+67.6%
109,382
+85.2%
0.00%
Q1 2021$74,000
-46.8%
59,077
-18.0%
0.00%
Q4 2020$139,000
-81.5%
72,075
-75.9%
0.00%
Q3 2020$751,000
+698.9%
299,253
+660.9%
0.00%
Q1 2020$94,00039,3270.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders